Our Pricing

Get Mounjaro Prescription - All Doses 2.5mg to 15mg

Published on: June 03, 2026

Accessing a Mounjaro prescription UK all doses has become simpler through registered online pharmacies offering the complete tirzepatide dose range. At Cured Pharmacy, our UK-registered clinical team provides free consultations and can prescribe any Mounjaro strength from the starter 2.5mg dose through to the maximum 15mg maintenance dose, with transparent pricing from £124.99 and discreet home delivery across the United Kingdom.

Understanding Mounjaro's Complete Dose Range

Mounjaro (tirzepatide) is available in six distinct dose strengths in the UK: 2.5mg, 5mg, 7.5mg, 10mg, 12.5mg, and 15mg, each administered as a once-weekly subcutaneous injection [1]. This graduated dosing schedule allows prescribers to tailor treatment intensity based on individual response and tolerance, starting with the lowest 2.5mg dose and escalating every four weeks as clinically appropriate.

The MHRA-approved titration protocol typically begins at 2.5mg for the first four weeks, increasing to 5mg for the next four weeks, then progressing through 7.5mg, 10mg, and 12.5mg before reaching the maximum maintenance dose of 15mg [1]. This stepwise approach minimises gastrointestinal side effects whilst optimising weight reduction outcomes, with clinical trials demonstrating that higher maintenance doses correlate with greater average weight loss percentages [2].

Each Mounjaro KwikPen contains four pre-filled doses of a single strength, meaning patients typically require one pen per month during each dose plateau. Your UK prescriber will determine the appropriate starting dose and escalation schedule based on your baseline BMI, metabolic health markers, tolerance to treatment, and weight loss progress during follow-up consultations.

How Mounjaro Tirzepatide Works for Weight Loss

Tirzepatide represents the first dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist licensed for weight management in the UK [1]. By activating both incretin pathways simultaneously, Mounjaro produces more pronounced effects on appetite suppression, gastric emptying, and insulin sensitivity compared to single-pathway GLP-1 treatments.

In the landmark SURMOUNT-1 trial, participants receiving the 15mg maintenance dose achieved an average body weight reduction of 22.5% over 72 weeks, compared to 2.4% with placebo [2]. The dual-receptor mechanism appears to enhance satiety signalling in the hypothalamus whilst improving post-prandial glucose control, creating synergistic metabolic benefits that extend beyond simple calorie restriction.

Clinical observations show that tirzepatide's effects typically become noticeable within the first four weeks of treatment, with progressive weight reduction continuing throughout the dose escalation phase. Maximum efficacy generally occurs after patients reach their optimal maintenance dose, which varies between individuals based on response and tolerability.

Comparing Dual-Pathway vs Single-Pathway Treatments

Head-to-head trials demonstrate that tirzepatide's dual GIP/GLP-1 activation produces superior weight loss outcomes compared to semaglutide-based single-pathway treatments at equivalent treatment durations [3]. The GIP component appears to amplify the metabolic effects of GLP-1 agonism, though the precise mechanisms underlying this synergy remain an active area of research within endocrinology.

Mounjaro Prescription UK All Doses: The Assessment Process

Obtaining a Mounjaro prescription through Cured Pharmacy requires completion of a comprehensive online clinical assessment reviewed by UK-registered prescribers. The consultation evaluates your current BMI, weight loss history, existing medical conditions, concurrent medications, and contraindications to ensure tirzepatide represents a safe and appropriate treatment option for your individual circumstances.

UK prescribing guidelines typically require a BMI of 30 kg/m² or above, or 27 kg/m² or above with at least one weight-related comorbidity such as type 2 diabetes, hypertension, or obstructive sleep apnoea [4]. Your prescriber will also assess for absolute contraindications including personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, or severe gastrointestinal disease.

Once approved, your prescription will specify the starting dose (typically 2.5mg) and provide guidance on the escalation schedule. Follow-up consultations occur at regular intervals to monitor treatment response, adjust dosing as needed, and address any side effects. This ongoing clinical oversight ensures you progress safely through the complete dose range whilst maximising therapeutic benefits.

What to Expect During Your Consultation

The online assessment takes under three minutes to complete and covers essential medical history questions about cardiovascular health, endocrine disorders, gastrointestinal conditions, and current medications. Our clinical team reviews submissions within hours, and approved prescriptions are typically dispensed the same working day with discreet next-day delivery options available across the UK.

Mounjaro Pricing Across All Dose Strengths

At Cured Pharmacy, Mounjaro is available from £124.99 with transparent upfront pricing displayed before you begin your clinical consultation. Unlike some providers who reveal costs only after assessment approval, we believe patients deserve clarity on treatment expenses from the outset, enabling informed decisions about long-term weight management strategies.

The price structure reflects the dose strength prescribed, as higher-dose pens contain greater quantities of active tirzepatide per injection. Patients typically start at the lower end of the pricing spectrum with 2.5mg starter doses, with costs adjusting as treatment progresses through the escalation protocol toward maintenance doses. Our pricing remains competitive compared to typical UK market rates whilst guaranteeing genuine MHRA-licensed medication dispensed by our GPhC-registered pharmacy.

We frequently offer promotional discounts for weight loss treatments, and patients can check our website for current offers before starting their assessment. All prices include the clinical consultation fee, prescription issuance, medication supply, and standard delivery, with no hidden charges added at checkout.

Managing Side Effects Across Different Mounjaro Doses

Gastrointestinal side effects represent the most commonly reported adverse events with tirzepatide treatment, including nausea, diarrhoea, vomiting, constipation, and abdominal discomfort [1]. These symptoms typically emerge during dose escalation phases and tend to diminish over subsequent weeks as physiological tolerance develops. The graduated titration schedule specifically aims to minimise these effects by allowing gradual adaptation to increasing drug concentrations.

Clinical trial data indicates that gastrointestinal adverse events occur more frequently at higher doses, with approximately 20-30% of patients on 15mg maintenance doses reporting nausea compared to 10-15% on 2.5mg starter doses [2]. Most cases are mild to moderate in severity and resolve without requiring treatment discontinuation, though prescribers may slow dose escalation or maintain patients at lower maintenance doses if tolerability issues persist.

Practical strategies to reduce side effects include taking injections with food, staying well-hydrated, eating smaller frequent meals rather than large portions, and avoiding high-fat foods that slow gastric emptying further. If you experience persistent or severe gastrointestinal symptoms, contact your prescriber before your next scheduled dose increase, as they may recommend extending the current dose plateau or adjusting the escalation timeline.

When to Seek Medical Advice

Whilst most side effects are self-limiting, certain symptoms warrant immediate medical attention including severe persistent abdominal pain (potential pancreatitis), visual changes, signs of thyroid lumps, or symptoms of gallbladder disease. Your prescriber will provide comprehensive safety information during your consultation, and our clinical team remains available for follow-up queries throughout your treatment journey.

Alternatives to Mounjaro Available at Cured Pharmacy

For patients who may not be suitable candidates for tirzepatide or prefer alternative mechanisms of action, Cured Pharmacy offers a comprehensive range of MHRA-licensed weight loss treatments. Wegovy (semaglutide) represents another once-weekly injectable GLP-1 receptor agonist that demonstrated average weight reductions of 14.9% over 68 weeks in the STEP-1 trial [5], offering proven efficacy through a single-pathway mechanism.

Saxenda (liraglutide) provides a daily injection option for patients who prefer more frequent lower-dose administration, whilst oral treatments including Orlistat and Xenical offer non-injectable alternatives that work by reducing dietary fat absorption in the gastrointestinal tract. Each treatment carries distinct efficacy profiles, side effect patterns, and dosing requirements that your prescriber will discuss during your consultation.

Our clinical team considers multiple factors when recommending the most appropriate weight loss medication, including your BMI, previous treatment responses, injection preferences, budget considerations, and specific metabolic health goals. The free online consultation ensures you receive personalised guidance rather than a one-size-fits-all approach to weight management.

Scientific References

1. Electronic Medicines Compendium. (2023). Mounjaro 2.5 mg solution for injection in pre-filled pen - Summary of Product Characteristics. Retrieved from https://www.medicines.org.uk/emc/product/14829 [accessed 13 August 2026]
2. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205-218. https://doi.org/10.1056/NEJMoa2206038 [accessed 13 August 2026]
3. Frías, J. P., Davies, M. J., Rosenstock, J., et al. (2021). Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes. New England Journal of Medicine, 385(6), 503-515. https://doi.org/10.1056/NEJMoa2107519 [accessed 13 August 2026]
4. National Institute for Health and Care Excellence. (2023). Obesity: identification, assessment and management (CG189). Retrieved from https://www.nice.org.uk/guidance/cg189 [accessed 13 August 2026]
5. Wilding, J. P. H., Batterham, R. L., Calanna, S., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989-1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
6. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
7. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
8. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Individual results may vary, and weight loss outcomes depend on multiple factors including diet, exercise, and adherence to treatment. Mounjaro is a prescription-only medicine and is subject to availability and prescriber approval.